Aerpio Pharmaceuticals, Inc.
NASDAQ: ARPO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 12
- Headquarters
- Blue Ash, United States
- IPO year
- 2018
- Market cap
- $53.7M
- Website
- http://www.aerpio.com
Loading ARPO…
Loading profile data…Frequently asked questions about ARPO
What does Aerpio Pharmaceuticals, Inc. (ARPO) do?
Aerpio Pharmaceuticals Inc., a biopharmaceutical enterprise headquartered in Blue Ash, Ohio, currently employs 27 full-time staff. The company's core mission revolves around the research and development of therapeutic solutions for ocular diseases. Its product pipeline is spearheaded by AKB-9778, with two additional programs, AKB-4924 and ARP-15...
Where does ARPO trade?
Aerpio Pharmaceuticals, Inc. (ARPO) trades on the NASDAQ Capital Market.
What sector is ARPO in?
Aerpio Pharmaceuticals, Inc. (ARPO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Where is Aerpio Pharmaceuticals, Inc. headquartered?
Aerpio Pharmaceuticals, Inc. is headquartered in United States.
Does ARPO pay a dividend?
Aerpio Pharmaceuticals, Inc. (ARPO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ARPO go public?
Aerpio Pharmaceuticals, Inc. (ARPO) completed its initial public offering in 2018.